Javed Suleman

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Assays of different aspects of haemostasis – what do they measure?

Risk Prediction of Contrast-Induced Nephropathy

Contrast Medium-Induced Acute Kidney Injury

Acute kidney injury

Universal Definition of Myocardial Infarction

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients*

Global epidemiology and outcomes of acute kidney injury

Epidemiology and Prognostic Implications of Contrast-Induced Nephropathy

Fenoldopam Mesylate for the Prevention of Contrast-Induced Nephropathy

Epidemiology of aortic aneurysm repair in the United States from 2000 to 2010

The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm

Nephrotoxic Effects in High-Risk Patients Undergoing Angiography

Peri-procedural myocardial injury: 2005 update

Third Universal Definition of Myocardial Infarction

The use of the VerifyNowsystem to monitor antiplatelet therapy: A review of the current evidence

Contrast-Induced Acute Kidney Injury and Risk of Adverse Clinical Outcomes After Coronary Angiography

Guidelines for the Early Management of Patients With Acute Ischemic Stroke

Systematic review and meta-analysis of the early and late outcomes of open and endovascular repair of abdominal aortic aneurysm

Diabetic Nephropathy: Diagnosis, Prevention, and Treatment

Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery

¿Mejora el uso de abciximab intracoronario el resultado del intervencionismo percutáneo? Estudio prospectivo y aleatorizado

Endovascular repair of abdominal aortic aneurysm

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Does Intracoronary Abciximab Improve the Outcome of Percutaneous Coronary Interventions? A Randomized Controlled Trial

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Serum creatinine ratio: A novel predictor of mortality after percutaneous coronary intervention in patients with normal and abnormal renal function

Impact of the Everolimus-Eluting Stent on Stent Thrombosis

Open Versus Endovascular Stent Graft Repair of Abdominal Aortic Aneurysms

Changing trends in incidence and predictors of radiographic contrast nephropathy after percutaneous coronary intervention with use of fenoldopam

Effectiveness of tirofiban, eptifibatide, and abciximab in minimizing myocardial necrosis during percutaneous coronary intervention (TEAM pilot study)**There is no conflict of interest either real or perceived of any author in the publication of this manuscript.